Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Details

Connection

Barry Uretsky to Coronary Artery Disease

This is a "connection" page, showing publications Barry Uretsky has written about Coronary Artery Disease.

 
Connection Strength
  
 
 
13.282
  
  1. Chaus A, Uretsky BF. Flow Matters: Optimizing Invasive Coronary Physiology to Improve Long-Term Outcomes. Cardiovasc Drugs Ther. 2024 Oct; 38(5):971-972.
    View in: PubMed
    Score: 0.725
  2. Chaus A, Uretsky BF. "CHIP-ping" away at the definition of PCI "complexity" and "risk". Catheter Cardiovasc Interv. 2023 08; 102(2):396-397.
    View in: PubMed
    Score: 0.673
  3. Chaus A, Uretsky BF. Bifurcation stenting: If the shoe doesn't fit. Catheter Cardiovasc Interv. 2023 01; 101(1):58-59.
    View in: PubMed
    Score: 0.648
  4. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Miller K, Biscaglia S, Hakeem A. Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure. JACC Cardiovasc Interv. 2022 11 14; 15(21):2192-2202.
    View in: PubMed
    Score: 0.642
  5. Chaus A, Uretsky BF. Bioresorbable Vascular Scaffolds: a Dissolving Dream? Cardiovasc Drugs Ther. 2023 02; 37(1):1-3.
    View in: PubMed
    Score: 0.642
  6. Vallurupalli S, Hess E, Plomondon ME, Park K, Waldo SW, Agarwal S, Uretsky BF. Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program. Catheter Cardiovasc Interv. 2022 04; 99(5):1491-1497.
    View in: PubMed
    Score: 0.612
  7. Chaus A, Uretsky BF. SYNTAX Score for Clinical Decision-Making: Necessity, Nicety, or Neither? Cardiovasc Revasc Med. 2022 04; 37:90-91.
    View in: PubMed
    Score: 0.606
  8. Vallurupalli S, Salehi N, Agarwal S, Hasan R, Hassan A, Siraj A, Madmani ME, Rafeedheen R, Ayan M, Al-Hawwas M, Hakeem A, Uretsky BF. Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention. Catheter Cardiovasc Interv. 2021 11 15; 98(6):1021-1026.
    View in: PubMed
    Score: 0.591
  9. Hakeem A, Hou L, Shah K, Agarwal SK, Almomani A, Edupuganti M, Kasula S, Pothineni NV, Al-Hawwas M, Miller K, Zakir R, Ghosh B, Uretsky BF. Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry. Catheter Cardiovasc Interv. 2022 02; 99(3):714-722.
    View in: PubMed
    Score: 0.581
  10. Agarwal SK, Hakeem A, Hasan R, Ayan M, Siraj A, Madmani ME, Rafeedheen R, Salehi N, Kasula S, Hacioglu Y, Miller K, Vallurupalli S, Al-Hawwas M, Uretsky BF. Fractional Flow Reserve After Functionally Optimized Coronary Intervention Predicts Very Long-Term Outcomes. JACC Cardiovasc Interv. 2021 02 08; 14(3):355-356.
    View in: PubMed
    Score: 0.568
  11. Uretsky BF, Agarwal SK, Vallurupalli S, Al-Hawwas M, Hasan R, Miller K, Hakeem A. Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention. J Am Heart Assoc. 2020 02 04; 9(3):e015073.
    View in: PubMed
    Score: 0.529
  12. Hakeem A, Ghosh B, Shah K, Agarwal S, Kasula S, Hacioglu Y, Bhatti S, Ahmed Z, Uretsky B. Incremental Prognostic Value of Post-Intervention Pd/Pa in Patients Undergoing Ischemia-Driven Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2019 10 28; 12(20):2002-2014.
    View in: PubMed
    Score: 0.520
  13. Hakeem A, Uretsky BF. Role of Postintervention Fractional Flow Reserve to Improve Procedural and Clinical Outcomes. Circulation. 2019 01 29; 139(5):694-706.
    View in: PubMed
    Score: 0.493
  14. Abdel-Karim AR, Uretsky BF. The importance of malapposition in angiographically optimized stenting in contemporaneous interventions. Expert Rev Cardiovasc Ther. 2018 Aug; 16(8):599-605.
    View in: PubMed
    Score: 0.475
  15. Uretsky BF. All stent strut malappositions are not created equal. Catheter Cardiovasc Interv. 2018 02 15; 91(3):376-377.
    View in: PubMed
    Score: 0.462
  16. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Classification of mechanisms of strut malapposition after angiographically optimized stent implantation: An optical coherence tomography study. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):225-232.
    View in: PubMed
    Score: 0.430
  17. Vallurupalli S, Kasula S, Kumar Agarwal S, Pothineni NVK, Abualsuod A, Hakeem A, Ahmed Z, Uretsky BF. A novel stent inflation protocol improves long-term outcomes compared with rapid inflation/deflation deployment method. Catheter Cardiovasc Interv. 2017 Aug 01; 90(2):233-240.
    View in: PubMed
    Score: 0.429
  18. Agrawal M, Hakeem A, Ahmed Z, Uretsky BF. Utility of Frequency Domain Optical Coherence Tomographic Evaluation of Angiographically Optimized Stented Lesions. J Invasive Cardiol. 2016 Mar; 28(3):94-7.
    View in: PubMed
    Score: 0.403
  19. Hakeem A, Uretsky BF. "Just do it!" redux. Catheter Cardiovasc Interv. 2015 May; 85(6):977-8.
    View in: PubMed
    Score: 0.381
  20. Hakeem A, Garg N, Bhatti S, Rajpurohit N, Ahmed Z, Uretsky BF. Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data. J Am Heart Assoc. 2013 Aug 07; 2(4):e000354.
    View in: PubMed
    Score: 0.337
  21. Uretsky BF. Time for left main stenting in patients with LV dysfunction? Proceed with caution! Catheter Cardiovasc Interv. 2010 Mar 01; 75(4):594-5.
    View in: PubMed
    Score: 0.266
  22. Uretsky BF, Birnbaum Y, Osman A, Gupta R, Paniagua O, Chamoun A, Pohwani A, Lui C, Lev E, McGehee T, Kumar D, Akhtar A, Anzuini A, Schwarz ER, Wang FW. Distal myocardial protection with intracoronary beta blocker when added to a Gp IIb/IIIa platelet receptor blocker during percutaneous coronary intervention improves clinical outcome. Catheter Cardiovasc Interv. 2008 Oct 01; 72(4):488-97.
    View in: PubMed
    Score: 0.241
  23. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol. 2004 Oct 06; 44(7):1343-53.
    View in: PubMed
    Score: 0.183
  24. Collet C, Johnson NP, Mizukami T, Fearon WF, Berry C, Sonck J, Collison D, Koo BK, Meneveau N, Agarwal SK, Uretsky B, Hakeem A, Doh JH, Da Costa BR, Oldroyd KG, Leipsic JA, Morbiducci U, Taylor C, Ko B, Tonino PAL, Perera D, Shinke T, Chiastra C, Sposito AC, Leone AM, Muller O, Fournier S, Matsuo H, Adjedj J, Amabile N, Pir?th Z, Alfonso F, Rivero F, Ahn JM, Toth GG, Ihdayhid A, West NEJ, Amano T, Wyffels E, Munhoz D, Belmonte M, Ohashi H, Sakai K, Gallinoro E, Barbato E, Engstr?m T, Escaned J, Ali ZA, Kern MJ, Pijls NHJ, J?ni P, De Bruyne B. Impact of Post-PCI FFR Stratified by Coronary Artery. JACC Cardiovasc Interv. 2023 10 09; 16(19):2396-2408.
    View in: PubMed
    Score: 0.171
  25. Hamaya R, Goto S, Hwang D, Zhang J, Yang S, Lee JM, Hoshino M, Nam CW, Shin ES, Doh JH, Chen SL, Toth GG, Piroth Z, Hakeem A, Uretsky BF, Hokama Y, Tanaka N, Lim HS, Ito T, Matsuo A, Azzalini L, Leesar MA, Collet C, Koo BK, De Bruyne B, Kakuta T. Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention. Atherosclerosis. 2023 10; 383:117310.
    View in: PubMed
    Score: 0.170
  26. Wang FW, Osman A, Otero J, Stouffer GA, Waxman S, Afzal A, Anzuini A, Uretsky BF. Distal myocardial protection during percutaneous coronary intervention with an intracoronary beta-blocker. Circulation. 2003 Jun 17; 107(23):2914-9.
    View in: PubMed
    Score: 0.166
  27. Xenogiannis I, Rangan BV, Uyeda L, Banerjee S, Edson R, Bhatt DL, Goldman S, Holmes DR, Rao SV, Shunk K, Mavromatis K, Ramanathan K, Bavry AA, McFalls EO, Garcia S, Thai H, Uretsky BF, Latif F, Armstrong E, Ortiz J, Jneid H, Liu J, Aggrawal K, Conner TA, Wagner T, Karacsonyi J, Ventura B, Alsleben A, Lu Y, Shih MC, Brilakis ES. In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial). Am J Cardiol. 2022 01 01; 162:24-30.
    View in: PubMed
    Score: 0.149
  28. Biscaglia S, Uretsky BF, Tebaldi M, Erriquez A, Brugaletta S, Cerrato E, Quadri G, Spitaleri G, Colaiori I, Di Girolamo D, Scoccia A, Zucchetti O, D'Aniello E, Manfrini M, Pavasini R, Barbato E, Campo G. Angio-Based Fractional Flow Reserve, Functional Pattern of Coronary Artery Disease, and Prediction of Percutaneous Coronary Intervention Result: a Proof-of-Concept Study. Cardiovasc Drugs Ther. 2022 08; 36(4):645-653.
    View in: PubMed
    Score: 0.144
  29. Biscaglia S, Uretsky B, Barbato E, Collet C, Onuma Y, Jeremias A, Tebaldi M, Hakeem A, Kogame N, Sonck J, Escaned J, Serruys PW, Stone GW, Campo G. Invasive Coronary Physiology After Stent?Implantation: Another Step Toward Precision Medicine. JACC Cardiovasc Interv. 2021 02 08; 14(3):237-246.
    View in: PubMed
    Score: 0.142
  30. Xenogiannis I, Choi JW, Alaswad K, Khatri JJ, Doing AH, Dattilo P, Jaffer FA, Uretsky B, Krestyaninov O, Khelimskii D, Patel M, Mahmud E, Potluri S, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Jefferson BK, Patel T, Megaly MS, Hall AB, Vemmou E, Nikolakopoulos I, Rangan BV, Abdullah S, Garcia S, Banerjee S, Burke MN, Brilakis ES. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
    View in: PubMed
    Score: 0.131
  31. Tajti P, Karmpaliotis D, Alaswad K, Jaffer FA, Yeh RW, Patel M, Mahmud E, Choi JW, Burke MN, Doing AH, Dattilo P, Toma C, Smith AJC, Uretsky B, Holper E, Potluri S, Wyman RM, Kandzari DE, Garcia S, Krestyaninov O, Khelimskii D, Koutouzis M, Tsiafoutis I, Jaber W, Samady H, Moses JW, Lembo NJ, Parikh M, Kirtane AJ, Ali ZA, Doshi D, Xenogiannis I, Stanberry LI, Rangan BV, Ungi I, Banerjee S, Brilakis ES. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Prior Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv. 2019 03; 12(3):e007338.
    View in: PubMed
    Score: 0.124
  32. Saad M, Bavineni M, Uretsky BF, Vallurupalli S. Improved stent expansion with prolonged compared with short balloon inflation: A meta-analysis. Catheter Cardiovasc Interv. 2018 11 01; 92(5):873-880.
    View in: PubMed
    Score: 0.117
  33. Agarwal SK, Kasula S, Edupuganti MM, Raina S, Shailesh F, Almomani A, Payne JJ, Pothineni NV, Uretsky BF, Hakeem A. Clinical Decision-Making for the Hemodynamic "Gray Zone" (FFR 0.75-0.80) and Long-Term Outcomes. J Invasive Cardiol. 2017 Nov; 29(11):371-376.
    View in: PubMed
    Score: 0.109
  34. Agarwal SK, Kasula S, Hacioglu Y, Ahmed Z, Uretsky BF, Hakeem A. Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes. JACC Cardiovasc Interv. 2016 05 23; 9(10):1022-31.
    View in: PubMed
    Score: 0.102
  35. Sachdeva R, Uretsky BF, Mehta JL. Determining the significance of side branch lesion during bifurcation stenting. Am J Cardiol. 2011 Jun 15; 107(12):1794-5.
    View in: PubMed
    Score: 0.073
  36. Schwarz ER, Gupta R, Haager PK, vom Dahl J, Klues HG, Minartz J, Uretsky BF. Myocardial bridging in absence of coronary artery disease: proposal of a new classification based on clinical-angiographic data and long-term follow-up. Cardiology. 2009; 112(1):13-21.
    View in: PubMed
    Score: 0.059
  37. Wang FW, Uretsky BF, Freeman JL, Zhang D, Giordano SH, Goodwin JS. Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual? Catheter Cardiovasc Interv. 2008 Apr 01; 71(5):636-43.
    View in: PubMed
    Score: 0.058
  38. deFilippi C, Wasserman S, Rosanio S, Tiblier E, Sperger H, Tocchi M, Christenson R, Uretsky B, Smiley M, Gold J, Muniz H, Badalamenti J, Herzog C, Henrich W. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA. 2003 Jul 16; 290(3):353-9.
    View in: PubMed
    Score: 0.042
  39. Mueller RN, Uretsky BF, Hao L, Walker DH, Panomitros GE, Zornow MH. Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogram. Anesthesiology. 2002 Sep; 97(3):745-9.
    View in: PubMed
    Score: 0.040
  40. Zerbe T, Uretsky B, Kormos R, Armitage J, Wolyn T, Griffith B, Hardesty R, Duquesnoy R. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 1992 May-Jun; 11(3 Pt 2):S104-10.
    View in: PubMed
    Score: 0.019
  41. Pahl E, Fricker FJ, Armitage J, Griffith BP, Taylor S, Uretsky BF, Beerman LB, Zuberbuhler JR. Coronary arteriosclerosis in pediatric heart transplant survivors: limitation of long-term survival. J Pediatr. 1990 Feb; 116(2):177-83.
    View in: PubMed
    Score: 0.017
  42. Salinas G, Rangasetty UC, Uretsky BF, Birnbaum Y. The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame. J Cardiovasc Pharmacol Ther. 2007 Jun; 12(2):98-111.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.